scholarly journals New onset depression and anxiety in patients with an implantable cardioverter defibrillator during 24 months of follow-up

EP Europace ◽  
2021 ◽  
Vol 23 (Supplement_3) ◽  
Author(s):  
SS Pedersen ◽  
JC Nielsen ◽  
S Wehberg ◽  
OD Jorgensen ◽  
S Riahi ◽  
...  
Keyword(s):  
Implantable Cardioverter Defibrillator ◽  
Physical Functioning ◽  
Anxiety And Depression ◽  
Depression And Anxiety ◽  
Cardioverter Defibrillator ◽  
Type D ◽  
Anxiety Depression ◽  
First Time ◽  
New Onset

Abstract Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): Danish Heart Foundation OnBehalf DEFIB-WOMEN study group Background Patients adjust well to living with an implantable cardioverter defibrillator (ICD), but 20% develop anxiety and depression that may compromise their quality of life (QoL) and increase risk of ventricular tachyarrhythmias and mortality. Purpose We examined the incidence and correlates of new onset anxiety and depression during 24 months of follow-up in ICD patients without depression and anxiety. Methods Patients with a first-time ICD (n = 1040) enrolled in the national, multi-centre prospective observational DEFIB-WOMEN study completed questionnaires on anxiety, depression and physical QoL at baseline, 3-, 6-, 12-, and 24 months. Information on demographic and clinical data was obtained from the Danish Pacemaker and ICD Register. Results During 24 months of follow-up, 46-57 (4%-5%) patients developed new onset anxiety and 42-47 (4%-5%) new onset depression. The incidence of new onset comorbid anxiety and depression was higher with 69-80 (7%-8%). Age [HR:0.54; 95%CI:0.36-0.80], marital status [HR:1.66; 95%CI:1.01-2.73], secondary prevention indication [HR:1.43; 95%CI:1.00-2.04], Type D personality [HR:2.50; 95%CI:1.62-3.86], and lower self-reported physical functioning [HR:1.48; 95%CI:1.00-2.17] were associated with new onset anxiety during follow-up. Age [HR:0.57; 95%CI:0.37-0.89], higher self-reported physical functioning [HR:0.46; 95%CI:0.25-0.85], smoking [HR:2.13; 95%CI:1.33-3.40], Type D personality [HR:2.53; 95%CI: 1.57-4.05], and lower self-reported physical functioning [HR:1.64; 95%CI:1.08-2.48] were associated with new onset depression. Conclusion Between 4%-8% of patients with a first-time ICD with no anxiety or depression at baseline are at risk of new onset anxiety, depression, or comorbid anxiety and depression up to 24 months post implant, suggesting that safeguarding their QoL and prognosis warrants that we screen patients not only at baseline.

scholarly journals Anxiety, depression and cardiac anxiety in patients with implantable cardioverter-defibrillator according to gender and age

Rev Rene ◽  
2021 ◽  
Vol 22 ◽  
pp. e61117
Author(s):  
Isabelle Brigliadori Ignácio ◽  
Paolla Algarte Fernandes ◽  
Suellen Rodrigues de Oliveira Maier ◽  
Carina Aparecida Marost Dessotte
Keyword(s):  
Implantable Cardioverter Defibrillator ◽  
Statistical Significance ◽  
University Hospital ◽  
Anxiety And Depression ◽  
Depression Symptoms ◽  
Cross Sectional ◽  
Cardioverter Defibrillator ◽  
Cardiac Anxiety ◽  
Gender And Age ◽  
Anxiety Depression

Objective: to investigate the relationship between gender and age with symptoms of anxiety, depression and cardiac anxiety in patients with implantable cardioverter-defibrillator. Methods: cross-sectional study, with 76 patients with device attended in a university hospital. For data collection, a sociodemographic/clinical form and two validated scales were used in Brazil. In the analysis, the chi-square tests, exact Fischer and Mann-Whitney, with a significance level of 5% were adopted. Results: it was observed that the groups were homogeneous in terms of gender and age. Women presented higher medians in both anxiety and depression symptoms, with statistical significance. They also presented higher medians in symptoms of cardiac anxiety, but without statistical significance. Regarding age, no significant differences were found for the symptoms investigated. Conclusion: women presented more symptoms of anxiety and depression; however there was no relationship between the age of the patients and their symptoms.

scholarly journals Anxiety and depression symptoms in Danish patients with an implantable cardioverter-defibrillator: prevalence and association with indication and sex up to 2 years of follow-up (data from the national DEFIB-WOMEN study)

EP Europace ◽  
2020 ◽  
Vol 22 (12) ◽  
pp. 1830-1840
Author(s):  
Vivi Skibdal Frydensberg ◽  
Jens Brock Johansen ◽  
Sören Möller ◽  
Sam Riahi ◽  
Sonja Wehberg ◽  
...  
Keyword(s):  
Implantable Cardioverter Defibrillator ◽  
Depression Scale ◽  
Anxiety And Depression ◽  
Depression Symptoms ◽  
Depression Symptom ◽  
Icd Implantation ◽  
Cardioverter Defibrillator ◽  
Time Points ◽  
Mixed Modelling

Abstract Aims To investigate (i) the prevalence of anxiety and depression and (ii) the association between indication for implantable cardioverter-defibrillator (ICD) implantation and sex in relation to anxiety and depression up to 24 months’ follow-up. Methods and results Patients with a first-time ICD, participating in the national, multi-centre, prospective DEFIB-WOMEN study (n = 1496; 18% women) completed the Hospital Anxiety and Depression Scale at baseline, 3, 6, 12, and 24 months. Data were analysed using linear mixed modelling for longitudinal data. Patients with a secondary prophylactic indication (SPI) had higher mean anxiety scores than patients with a primary prophylactic indication (PPI) at baseline, 3, and 12 months and higher mean depression scores at all-time points, except at 24 months. Women had higher mean anxiety scores as compared to men at all-time points; however, only higher mean depression scores at baseline. Overall, women with SPI had higher anxiety and depression symptom scores than men with SPI. Symptoms decreased over time in both women and men. From baseline to follow-up, the prevalence of anxiety (score ≥8) was highest in patients with SPI (13.3–20.2%) as compared to patients with PPI (range 10.0–14.7%). The prevalence of depression was stable over the follow-up period in both groups (range 8.5–11.1%). Conclusion Patients with a SPI reported higher anxiety and depression scores as compared to patients with PPI. Women reported higher anxiety scores than men, but only higher depression scores at baseline. Women with SPI reported the highest anxiety and depression scores overall.

Computerized, interactive, multimedia cognitive-behavioural program for anxiety and depression in general practice

2003 ◽  
Vol 33 (2) ◽  
pp. 217-227 ◽  
Author(s):  
J. PROUDFOOT ◽  
D. GOLDBERG ◽  
A. MANN ◽  
B. EVERITT ◽  
I. MARKS ◽  
...  
Keyword(s):  
General Practice ◽  
Social Adjustment ◽  
Interactive Multimedia ◽  
Beck Anxiety Inventory ◽  
Anxiety And Depression ◽  
Care Practice ◽  
Depression And Anxiety ◽  
Cognitive Behavioural ◽  
Anxiety Depression

Background. Cognitive-behavioural therapy (CBT) brings about significant clinical improvement in anxiety and depression, but therapists are in short supply. We report the first phase of a randomized controlled trial of an interactive multimedia program of cognitive-behavioural techniques, Beating the Blues™ (BtB), in the treatment of patients in general practice with anxiety, depression or mixed anxiety/depression.Method. One hundred and sixty-seven adults suffering from anxiety and/or depression and not receiving any form of psychological treatment or counselling were randomly allocated to receive, with or without medication, BtB or treatment as usual (TAU). Measures were taken on five occasions: prior to treatment, 2 months later, and at 1, 3 and 6 months follow-up using the Beck Depression Inventory, Beck Anxiety Inventory and Work and Social Adjustment Scale.Results. Patients who received BtB showed significantly greater improvement in depression and anxiety compared to TAU by the end of treatment (2 months) and to 6 months follow-up. Symptom reduction was paralleled by improvement in work and social adjustment. There were no interactions of BtB with concomitant pharmacotherapy or duration of illness, but evidence, on the Beck Anxiety Inventory only, of interaction with primary care practice. Importantly, there was no interaction between the effects of BtB and baseline severity of depression, from which we conclude that the effects of the computer program are independent of starting level of depression.Conclusions. These results demonstrate that computerized interactive multimedia cognitive-behavioural techniques under minimal clinical supervision can bring about improvements in depression and anxiety, as well as in work and social adjustment, with and without pharmacotherapy and in patients with pre-treatment illness of durations greater or less than 6 months. Thus, our results indicate that wider dissemination of cognitive-behavioural techniques is possible for patients suffering from anxiety and/or depression.

scholarly journals Assessment of new-onset depression and anxiety associated with COVID-19

2021 ◽  
Vol 28 (1) ◽  
Author(s):  
Eman Hurissi ◽  
Ethar Abu-jabir ◽  
Amnah Mohammed ◽  
Mashael Mahnashi ◽  
Sana Alharbi ◽  
...  
Keyword(s):  
Epidemiological Studies ◽  
Anxiety And Depression ◽  
Depression And Anxiety ◽  
Online Questionnaire ◽  
Final Sample ◽  
Significant Difference ◽  
Patient Health ◽  
Males And Females ◽  
Arabian Population ◽  
New Onset

Abstract Background Psychological disorders are common among individuals who experienced COVID-19. Previous studies have shown that females report higher depression and anxiety than males. The present study aims to test the differences in depression and anxiety between males and females who have experienced COVID-19. This a descriptive, observational, comparative study, among Saudi Arabian population. A total of 686 participants have been recruited. Participants completed an online questionnaire that contains questions about sociodemographic, COVID-19, Generalized Anxiety Disorder (GAD-7) questionnaire, and Patient Health Questionnaire (PHQ-9) to measure anxiety and depression, respectively. Results Twenty-six percent of the participants were excluded and our final sample consisted of 507 participants (median age 23; 65% females). Of the final sample, 23% (118) have been previously diagnosed with COVID-19. There is no significant difference in GAD-7 and PHQ-9 scores between COVID-19- positive and COVID-19-negative populations. However, females who have experienced COVID-19 reported significantly higher GAD-7 and PHQ-9 scores compared to males. Conclusion The results of our study show that females are significantly at a higher risk for depression and anxiety as a result of COVID-19 infection compared to males. Further epidemiological studies are required for a better understanding of this correlation.

Long-term follow-up of Chagas heart disease patients receiving an implantable cardioverter-defibrillator for secondary prevention

2018 ◽  
Vol 41 (6) ◽  
pp. 583-588 ◽  
Author(s):  
Maria Licia Ribeiro Cury Pavão ◽  
Elerson Arfelli ◽  
Adilson Scorzoni-Filho ◽  
Anis Rassi ◽  
Antônio Pazin-Filho ◽  
...  
Keyword(s):  
Heart Disease ◽  
Secondary Prevention ◽  
Implantable Cardioverter Defibrillator ◽  
Cardioverter Defibrillator ◽  
Long Term Follow Up ◽  
Chagas Heart Disease

scholarly journals B-PO04-064 A PROSPECTIVE EVALUATION OF SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR INFECTIONS WITH MID TERM FOLLOW-UP

Heart Rhythm ◽  
2021 ◽  
Vol 18 (8) ◽  
pp. S304-S305
Author(s):  
Michael R. Gold ◽  
Mark P. Miller ◽  
Johan D. Aasbo ◽  
Raul Weiss ◽  
Martin C. Burke ◽  
...  
Keyword(s):  
Implantable Cardioverter Defibrillator ◽  
Prospective Evaluation ◽  
Cardioverter Defibrillator
Sign in / Sign up

Export Citation Format

Share Document